Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
APC |
adenomatous polyposis coli, transcript variant 3 |
FXC01190
|
FHC01190
|
FNC01190N
|
FNC01190C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
BCL2 |
B-cell CLL/lymphoma 2, transcript variant alpha |
FXC01250
|
FHC01250
|
FNC01250N
|
FNC01250C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
GSK3B |
glycogen synthase kinase 3 beta, transcript variant 2 |
FXC01477
|
FHC01477
|
FNC01477N
|
FNC01477C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
RHOA |
ras homolog family member A |
FXC01522
|
FHC01522
|
FNC01522N
|
FNC01522C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
JUN |
jun proto-oncogene |
FXC01532
|
FHC01532
|
FNC01532N
|
FNC01532C
|
CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
SMAD4 |
SMAD family member 4 |
FXC01560
|
FHC01560
|
FNC01560N
|
FNC01560C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
FXC01934
|
FHC01934
|
FNC01934N
|
FNC01934C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
SMAD3 |
SMAD family member 3, transcript variant 1 |
FXC02648
|
FHC02648
|
FNC02648N
|
FNC02648C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
SMAD2 |
SMAD family member 2, transcript variant 1 |
FXC03382
|
FHC03382
|
FNC03382N
|
FNC03382C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03542
|
FHC03542
|
FNC03542N
|
FNC03542C
|
MLH1 |
mutL homolog 1, transcript variant 1 |
FXC03755
|
FHC03755
|
FNC03755N
|
FNC03755C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03984
|
FHC03984
|
FNC03984N
|
FNC03984C
|
APPL1 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
FXC04145
|
FHC04145
|
FNC04145N
|
FNC04145C
|
BIRC5 |
baculoviral IAP repeat containing 5, transcript variant 1 |
FXC04272
|
FHC04272
|
FNC04272N
|
FNC04272C
|
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa, transcript variant 1 |
FXC07714
|
FHC07714
|
FNC07714N
|
FNC07714C
|
MSH2 |
mutS homolog 2, transcript variant 1 |
FXC07773
|
FHC07773
|
FNC07773N
|
FNC07773C
|
CYCS |
cytochrome c, somatic |
FXC07778
|
FHC07778
|
FNC07778N
|
FNC07778C
|
CASP9 |
caspase 9, transcript variant alpha |
FXC08062
|
FHC08062
|
FNC08062N
|
FNC08062C
|
ARAF |
A-Raf proto-oncogene, serine/threonine kinase, transcript variant 1 |
FXC08066
|
FHC08066
|
FNC08066N
|
FNC08066C
|
MSH6 |
mutS homolog 6, transcript variant 1 |
FXC08173
|
FHC08173
|
FNC08173N
|
FNC08173C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
CASP3 |
caspase 3, apoptosis-related cysteine peptidase, transcript variant alpha |
FXC08865
|
FHC08865
|
FNC08865N
|
FNC08865C
|
ANAPC2 |
anaphase promoting complex subunit 2 |
FXC10289
|
FHC10289
|
FNC10289N
|
FNC10289C
|
PROC |
protein C (inactivator of coagulation factors Va and VIIIa) |
FXC10312
|
FHC10312
|
FNC10312N
|
FNC10312C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC10454
|
FHC10454
|
FNC10454N
|
FNC10454C
|
BAX |
BCL2-associated X protein, transcript variant beta |
FXC10662
|
FHC10662
|
FNC10662N
|
FNC10662C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
DCC |
DCC netrin 1 receptor |
FXC10740
|
FHC10740
|
FNC10740N
|
FNC10740C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
AXIN1 |
axin 1, transcript variant 2 |
FXC11116
|
FHC11116
|
FNC11116N
|
FNC11116C
|
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box), transcript variant 4 |
FXC11660
|
FHC11660
|
FNC11660N
|
FNC11660C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
AXIN2 |
axin 2 |
FXC11955
|
FHC11955
|
FNC11955N
|
FNC11955C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
MSH3 |
mutS homolog 3 |
FXC12698
|
FHC12698
|
FNC12698N
|
FNC12698C
|
LEF1 |
lymphoid enhancer-binding factor 1, transcript variant 2 |
FXC16601
|
FHC16601
|
FNC16601N
|
FNC16601C
|
RALGDS |
ral guanine nucleotide dissociation stimulator, transcript variant 1 |
FXC16602
|
FHC16602
|
|
|
TCF7L1 |
transcription factor 7-like 1 (T-cell specific, HMG-box) |
FXC21071
|
FHC21071
|
FNC21071N
|
FNC21071C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
TCF7 |
transcription factor 7 (T-cell specific, HMG-box), transcript variant 1 |
FXC22279
|
FHC22279
|
FNC22279N
|
FNC22279C
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
RB1 |
retinoblastoma 1 |
FXC01227
|
FHC01227
|
FNC01227N
|
FNC01227C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
JAK1 |
Janus kinase 1 |
FXC01306
|
FHC01306
|
FNC01306N
|
FNC01306C
|
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
FXC01313
|
FHC01313
|
FNC01313N
|
FNC01313C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor), transcript variant 2 |
FXC01466
|
FHC01466
|
FNC01466N
|
FNC01466C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
IKBKG |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, transcript variant 3 |
FXC01524
|
FHC01524
|
FNC01524N
|
FNC01524C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
PLD1 |
phospholipase D1, phosphatidylcholine-specific, transcript variant 2 |
FXC01544
|
FHC01544
|
FNC01544N
|
FNC01544C
|
CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
SMAD4 |
SMAD family member 4 |
FXC01560
|
FHC01560
|
FNC01560N
|
FNC01560C
|
PRKCSH |
protein kinase C substrate 80K-H, transcript variant 2 |
FXC01870
|
FHC01870
|
FNC01870N
|
FNC01870C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
E2F2 |
E2F transcription factor 2 |
FXC02567
|
FHC02567
|
FNC02567N
|
FNC02567C
|
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
FXC02618
|
FHC02618
|
FNC02618N
|
FNC02618C
|
SMAD3 |
SMAD family member 3, transcript variant 1 |
FXC02648
|
FHC02648
|
FNC02648N
|
FNC02648C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
FXC03080
|
FHC03080
|
FNC03080N
|
FNC03080C
|
BCL2L1 |
BCL2-like 1, transcript variant 1 |
FXC03091
|
FHC03091
|
FNC03091N
|
FNC03091C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
SMAD2 |
SMAD family member 2, transcript variant 1 |
FXC03382
|
FHC03382
|
FNC03382N
|
FNC03382C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, transcript variant 1 |
FXC03657
|
FHC03657
|
FNC03657N
|
FNC03657C
|
ARHGEF6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6, transcript variant 1 |
FXC04167
|
FHC04167
|
FNC04167N
|
FNC04167C
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A, transcript variant 1 |
FXC06624
|
FHC06624
|
FNC06624N
|
FNC06624C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 2 |
FXC07774
|
FHC07774
|
FNC07774N
|
FNC07774C
|
CASP9 |
caspase 9, transcript variant alpha |
FXC08062
|
FHC08062
|
FNC08062N
|
FNC08062C
|
ARAF |
A-Raf proto-oncogene, serine/threonine kinase, transcript variant 1 |
FXC08066
|
FHC08066
|
FNC08066N
|
FNC08066C
|
CDK4 |
cyclin-dependent kinase 4 |
FXC08159
|
FHC08159
|
FNC08159N
|
FNC08159C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
RALBP1 |
ralA binding protein 1 |
FXC08672
|
FHC08672
|
FNC08672N
|
FNC08672C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
CDK6 |
cyclin-dependent kinase 6, transcript variant 1 |
FXC10565
|
FHC10565
|
FNC10565N
|
FNC10565C
|
RAD51 |
RAD51 recombinase, transcript variant 1 |
FXC10574
|
FHC10574
|
FNC10574N
|
FNC10574C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
TGFA |
transforming growth factor, alpha |
FXC10823
|
FHC10823
|
FNC10823N
|
FNC10823C
|
CHUK |
conserved helix-loop-helix ubiquitous kinase |
FXC10858
|
FHC10858
|
FNC10858N
|
FNC10858C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
FXC11836
|
FHC11836
|
FNC11836N
|
FNC11836C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 1 |
FXC11986
|
FHC11986
|
FNC11986N
|
FNC11986C
|
E2F3 |
E2F transcription factor 3, transcript variant 1 |
FXC12471
|
FHC12471
|
FNC12471N
|
FNC12471C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
VEGFA |
vascular endothelial growth factor A, transcript variant 6 |
FXC13139
|
FHC13139
|
FNC13139N
|
FNC13139C
|
RALGDS |
ral guanine nucleotide dissociation stimulator, transcript variant 1 |
FXC16602
|
FHC16602
|
|
|
RALB |
v-ral simian leukemia viral oncogene homolog B |
FXC21157
|
FHC21157
|
FNC21157N
|
FNC21157C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
VEGFA |
vascular endothelial growth factor A
|
FXC22633
|
FHC22633
|
|
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
BRCA2 |
BRCA2, DNA repair associated |
FXC24976
|
FHC24976
|
FNC24976N
|
FNC24976C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
E2F1 |
E2F transcription factor 1 |
FXC26966
|
FHC26966
|
FNC26966N
|
FNC26966C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
CAMK2A |
calcium/calmodulin-dependent protein kinase II alpha, transcript variant 2 |
FXC00158
|
FHC00158
|
FNC00158N
|
FNC00158C
|
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
FXC01207
|
FHC01207
|
FNC01207N
|
FNC01207C
|
RB1 |
retinoblastoma 1 |
FXC01227
|
FHC01227
|
FNC01227N
|
FNC01227C
|
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
FXC01262
|
FHC01262
|
FNC01262N
|
FNC01262C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
IGF1 |
insulin-like growth factor 1 (somatomedin C), transcript variant 4 |
FXC01347
|
FHC01347
|
FNC01347N
|
FNC01347C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
CALM3 |
calmodulin 3 (phosphorylase kinase, delta) |
FXC01403
|
FHC01403
|
FNC01403N
|
FNC01403C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
GRB2 |
growth factor receptor-bound protein 2, transcript variant 1 |
FXC01485
|
FHC01485
|
FNC01485N
|
FNC01485C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1), transcript variant 1 |
FXC01536
|
FHC01536
|
FNC01536N
|
FNC01536C
|
CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
IGF1R |
insulin-like growth factor 1 receptor, transcript variant 2 |
FXC01578
|
FHC01578
|
FNC01578N
|
FNC01578C
|
PLCG1 |
phospholipase C, gamma 1, transcript variant 1 |
FXC01646
|
FHC01646
|
FNC01646N
|
FNC01646C
|
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta, transcript variant 6 |
FXC01765
|
FHC01765
|
FNC01765N
|
FNC01765C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS2 |
son of sevenless homolog 2 (Drosophila) |
FXC02373
|
FHC02373
|
FNC02373N
|
FNC02373C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
E2F2 |
E2F transcription factor 2 |
FXC02567
|
FHC02567
|
FNC02567N
|
FNC02567C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
FXC03080
|
FHC03080
|
FNC03080N
|
FNC03080C
|
PRKCA |
protein kinase C, alpha |
FXC03611
|
FHC03611
|
FNC03611N
|
FNC03611C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
PRKCG |
protein kinase C, gamma |
FXC03659
|
FHC03659
|
FNC03659N
|
FNC03659C
|
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1, transcript variant 3 |
FXC03742
|
FHC03742
|
FNC03742N
|
FNC03742C
|
CAMK2B |
calcium/calmodulin-dependent protein kinase II beta, transcript variant 5 |
FXC04424
|
FHC04424
|
FNC04424N
|
FNC04424C
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
FXC05918
|
FHC05918
|
FNC05918N
|
FNC05918C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
ARAF |
A-Raf proto-oncogene, serine/threonine kinase, transcript variant 1 |
FXC08066
|
FHC08066
|
FNC08066N
|
FNC08066C
|
CDK4 |
cyclin-dependent kinase 4 |
FXC08159
|
FHC08159
|
FNC08159N
|
FNC08159C
|
CALML3 |
calmodulin-like 3 |
FXC09388
|
FHC09388
|
FNC09388N
|
FNC09388C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
PTEN |
phosphatase and tensin homolog, transcript variant 1 |
FXC09870
|
FHC09870
|
FNC09870N
|
FNC09870C
|
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
FXC10206
|
FHC10206
|
FNC10206N
|
FNC10206C
|
CAMK2G |
calcium/calmodulin-dependent protein kinase II gamma, transcript variant 2 |
FXC10307
|
FHC10307
|
FNC10307N
|
FNC10307C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
PRKCB |
protein kinase C, beta, transcript variant 2 |
FXC10533
|
FHC10533
|
FNC10533N
|
FNC10533C
|
CDK6 |
cyclin-dependent kinase 6, transcript variant 1 |
FXC10565
|
FHC10565
|
FNC10565N
|
FNC10565C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
MDM2 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase, transcript variant 1 |
FXC10775
|
FHC10775
|
FNC10775N
|
FNC10775C
|
TGFA |
transforming growth factor, alpha |
FXC10823
|
FHC10823
|
FNC10823N
|
FNC10823C
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
FXC11491
|
FHC11491
|
FNC11491N
|
FNC11491C
|
CALM2 |
calmodulin 2 (phosphorylase kinase, delta), transcript variant 2 |
FXC11793
|
FHC11793
|
FNC11793N
|
FNC11793C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
E2F3 |
E2F transcription factor 3, transcript variant 1 |
FXC12471
|
FHC12471
|
FNC12471N
|
FNC12471C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
CALML5 |
calmodulin-like 5 |
FXC23748
|
FHC23748
|
FNC23748N
|
FNC23748C
|
SHC4 |
SHC (Src homology 2 domain containing) family, member 4 |
FXC25382
|
FHC25382
|
FNC25382N
|
FNC25382C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
E2F1 |
E2F transcription factor 1 |
FXC26966
|
FHC26966
|
FNC26966N
|
FNC26966C
|
RNMT |
RNA (guanine-7-) methyltransferase, transcript variant 2 |
FXC00528
|
FHC00528
|
FNC00528N
|
FNC00528C
|
FZR1 |
fizzy/cell division cycle 20 related 1, transcript variant 2 |
FXC00776
|
FHC00776
|
FNC00776N
|
FNC00776C
|
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
RB1 |
retinoblastoma 1 |
FXC01227
|
FHC01227
|
FNC01227N
|
FNC01227C
|
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor), transcript variant 5 |
FXC01260
|
FHC01260
|
FNC01260N
|
FNC01260C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
IGF1 |
insulin-like growth factor 1 (somatomedin C), transcript variant 4 |
FXC01347
|
FHC01347
|
FNC01347N
|
FNC01347C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1), transcript variant 1 |
FXC01536
|
FHC01536
|
FNC01536N
|
FNC01536C
|
CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
IGF1R |
insulin-like growth factor 1 receptor, transcript variant 2 |
FXC01578
|
FHC01578
|
FNC01578N
|
FNC01578C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
E2F2 |
E2F transcription factor 2 |
FXC02567
|
FHC02567
|
FNC02567N
|
FNC02567C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
FXC03080
|
FHC03080
|
FNC03080N
|
FNC03080C
|
MITF |
microphthalmia-associated transcription factor, transcript variant 1 |
FXC03436
|
FHC03436
|
FNC03436N
|
FNC03436C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
FGF5 |
fibroblast growth factor 5, transcript variant 1 |
FXC05019
|
FHC05019
|
FNC05019N
|
FNC05019C
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
FXC05918
|
FHC05918
|
FNC05918N
|
FNC05918C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
ARAF |
A-Raf proto-oncogene, serine/threonine kinase, transcript variant 1 |
FXC08066
|
FHC08066
|
FNC08066N
|
FNC08066C
|
CDK4 |
cyclin-dependent kinase 4 |
FXC08159
|
FHC08159
|
FNC08159N
|
FNC08159C
|
FGF18 |
fibroblast growth factor 18 |
FXC08269
|
FHC08269
|
FNC08269N
|
FNC08269C
|
IL6 |
interleukin 6 |
FXC08788
|
FHC08788
|
FNC08788N
|
FNC08788C
|
FGF12 |
fibroblast growth factor 12, transcript variant 2 |
FXC09106
|
FHC09106
|
FNC09106N
|
FNC09106C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
PTEN |
phosphatase and tensin homolog, transcript variant 1 |
FXC09870
|
FHC09870
|
FNC09870N
|
FNC09870C
|
FGF13 |
fibroblast growth factor 13, transcript variant 1 |
FXC09990
|
FHC09990
|
FNC09990N
|
FNC09990C
|
FGF21 |
fibroblast growth factor 21 |
FXC10096
|
FHC10096
|
FNC10096N
|
FNC10096C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
FGFR1 |
fibroblast growth factor receptor 1, transcript variant 3 |
FXC10532
|
FHC10532
|
FNC10532N
|
FNC10532C
|
CDK6 |
cyclin-dependent kinase 6, transcript variant 1 |
FXC10565
|
FHC10565
|
FNC10565N
|
FNC10565C
|
FGF1 |
fibroblast growth factor 1 (acidic), transcript variant 1 |
FXC10599
|
FHC10599
|
FNC10599N
|
FNC10599C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
MDM2 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase, transcript variant 1 |
FXC10775
|
FHC10775
|
FNC10775N
|
FNC10775C
|
FGF11 |
fibroblast growth factor 11, transcript variant 1 |
FXC10818
|
FHC10818
|
FNC10818N
|
FNC10818C
|
FGF16 |
fibroblast growth factor 16 |
FXC11178
|
FHC11178
|
FNC11178N
|
FNC11178C
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
FXC11491
|
FHC11491
|
FNC11491N
|
FNC11491C
|
FGF3 |
fibroblast growth factor 3 |
FXC11767
|
FHC11767
|
FNC11767N
|
FNC11767C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
E2F3 |
E2F transcription factor 3, transcript variant 1 |
FXC12471
|
FHC12471
|
FNC12471N
|
FNC12471C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
MET |
MET proto-oncogene, receptor tyrosine kinase, transcript variant 2 |
FXC12649
|
FHC12649
|
FNC12649N
|
FNC12649C
|
PDGFC |
platelet derived growth factor C, transcript variant 1 |
FXC22085
|
FHC22085
|
FNC22085N
|
FNC22085C
|
FGF10 |
fibroblast growth factor 10 |
FXC22164
|
FHC22164
|
FNC22164N
|
FNC22164C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
FGF20 |
fibroblast growth factor 20 |
FXC23199
|
FHC23199
|
FNC23199N
|
FNC23199C
|
FGF17 |
fibroblast growth factor 17, transcript variant 1 |
FXC23209
|
FHC23209
|
FNC23209N
|
FNC23209C
|
FGF19 |
fibroblast growth factor 19 |
FXC24356
|
FHC24356
|
FNC24356N
|
FNC24356C
|
FGF4 |
fibroblast growth factor 4 |
FXC24357
|
FHC24357
|
FNC24357N
|
FNC24357C
|
FGF23 |
fibroblast growth factor 23
|
FXC24560
|
FHC24560
|
|
|
FGF9 |
fibroblast growth factor 9 |
FXC24958
|
FHC24958
|
FNC24958N
|
FNC24958C
|
FGF14 |
fibroblast growth factor 14, transcript variant 2 |
FXC25055
|
FHC25055
|
FNC25055N
|
FNC25055C
|
FGF7 |
fibroblast growth factor 7 |
FXC25383
|
FHC25383
|
FNC25383N
|
FNC25383C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
E2F1 |
E2F transcription factor 1 |
FXC26966
|
FHC26966
|
FNC26966N
|
FNC26966C
|
FASN |
fatty acid synthase |
FXC00314
|
FHC00314
|
FNC00314N
|
FNC00314C
|
TSHR |
thyroid stimulating hormone receptor, transcript variant 1 |
FXC01753
|
FHC01753
|
FNC01753N
|
FNC01753C
|
IFNA16 |
interferon, alpha 16 |
FXC02322
|
FHC02322
|
FNC02322N
|
FNC02322C
|
IFNA1 |
interferon, alpha 1 |
FXC03299
|
FHC03299
|
FNC03299N
|
FNC03299C
|
ZNF395 |
zinc finger protein 395 |
FXC03445
|
FHC03445
|
FNC03445N
|
FNC03445C
|
FAS |
Fas cell surface death receptor |
FXC04988
|
FHC04988
|
FNC04988N
|
FNC04988C
|
IL10 |
interleukin 10 |
FXC07552
|
FHC07552
|
FNC07552N
|
FNC07552C
|
CHGA |
chromogranin A, transcript variant 1 |
FXC07948
|
FHC07948
|
FNC07948N
|
FNC07948C
|
HLA-DMA |
major histocompatibility complex, class II, DM alpha |
FXC08554
|
FHC08554
|
FNC08554N
|
FNC08554C
|
CD40 |
CD40 molecule, TNF receptor superfamily member 5, transcript variant 1 |
FXC08629
|
FHC08629
|
FNC08629N
|
FNC08629C
|
FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
ELF2 |
E74-like factor 2 (ets domain transcription factor), transcript variant 2 |
FXC09540
|
FHC09540
|
FNC09540N
|
FNC09540C
|
GZMB |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
FXC10250
|
FHC10250
|
FNC10250N
|
FNC10250C
|
CD86 |
CD86 molecule, transcript variant 1 |
FXC10363
|
FHC10363
|
FNC10363N
|
FNC10363C
|
HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3
|
FXC10549
|
FHC10549
|
|
|
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1, transcript variant 1 |
FXC10550
|
FHC10550
|
FNC10550N
|
FNC10550C
|
PRF1 |
perforin 1 (pore forming protein), transcript variant 1 |
FXC11041
|
FHC11041
|
FNC11041N
|
FNC11041C
|
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
FXC11450
|
FHC11450
|
FNC11450N
|
FNC11450C
|
SLC26A3 |
solute carrier family 26 (anion exchanger), member 3 |
FXC11726
|
FHC11726
|
FNC11726N
|
FNC11726C
|
CGA |
glycoprotein hormones, alpha polypeptide, transcript variant 2 |
FXC12142
|
FHC12142
|
FNC12142N
|
FNC12142C
|
TPO |
thyroid peroxidase |
FXC15889
|
FHC15889
|
FNC15889N
|
FNC15889C
|
IFNA13 |
interferon, alpha 13 |
FXC15894
|
FHC15894
|
FNC15894N
|
FNC15894C
|
TSHB |
thyroid stimulating hormone, beta, transcript variant 1 |
FXC20489
|
FHC20489
|
FNC20489N
|
FNC20489C
|
CD28 |
CD28 molecule, transcript variant 1 |
FXC21287
|
FHC21287
|
FNC21287N
|
FNC21287C
|
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4, transcript variant 1 |
FXC21288
|
FHC21288
|
FNC21288N
|
FNC21288C
|
CD80 |
CD80 molecule |
FXC21656
|
FHC21656
|
FNC21656N
|
FNC21656C
|
THPO |
thrombopoietin, transcript variant 1 |
FXC21783
|
FHC21783
|
FNC21783N
|
FNC21783C
|
IFNA21 |
interferon, alpha 21 |
FXC23475
|
FHC23475
|
FNC23475N
|
FNC23475C
|
IFNA4 |
interferon, alpha 4 |
FXC23476
|
FHC23476
|
FNC23476N
|
FNC23476C
|
IFNA10 |
interferon, alpha 10 |
FXC23477
|
FHC23477
|
FNC23477N
|
FNC23477C
|
IFNA17 |
interferon, alpha 17 |
FXC23478
|
FHC23478
|
FNC23478N
|
FNC23478C
|
IFNA14 |
interferon, alpha 14 |
FXC23479
|
FHC23479
|
FNC23479N
|
FNC23479C
|
IFNA5 |
interferon, alpha 5 |
FXC23480
|
FHC23480
|
FNC23480N
|
FNC23480C
|
IFNA6 |
interferon, alpha 6 |
FXC23481
|
FHC23481
|
FNC23481N
|
FNC23481C
|
IFNA2 |
interferon, alpha 2 |
FXC23482
|
FHC23482
|
FNC23482N
|
FNC23482C
|
IFNA8 |
interferon, alpha 8 |
FXC23483
|
FHC23483
|
FNC23483N
|
FNC23483C
|
CD40LG |
CD40 ligand |
FXC27535
|
FHC27535
|
FNC27535N
|
FNC27535C
|
RBM45 |
RNA binding motif protein 45 |
FXC28752
|
FHC28752
|
FNC28752N
|
FNC28752C
|
IFNA7 |
interferon, alpha 7 |
FXC29362
|
FHC29362
|
FNC29362N
|
FNC29362C
|
IL2 |
interleukin 2 |
FXC31382
|
FHC31382
|
FNC31382N
|
FNC31382C
|
IL5 |
interleukin 5 |
FXC31397
|
FHC31397
|
FNC31397N
|
FNC31397C
|
IL4 |
interleukin 4, transcript variant 1 |
FXC31398
|
FHC31398
|
FNC31398N
|
FNC31398C
|
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
FXC01313
|
FHC01313
|
FNC01313N
|
FNC01313C
|
STAT6 |
signal transducer and activator of transcription 6, interleukin-4 induced, transcript variant 2 |
FXC01445
|
FHC01445
|
FNC01445N
|
FNC01445C
|
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor), transcript variant 2 |
FXC01466
|
FHC01466
|
FNC01466N
|
FNC01466C
|
JUN |
jun proto-oncogene |
FXC01532
|
FHC01532
|
FNC01532N
|
FNC01532C
|
FOXP3 |
forkhead box P3, transcript variant 1 |
FXC02319
|
FHC02319
|
FNC02319N
|
FNC02319C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
SMAD3 |
SMAD family member 3, transcript variant 1 |
FXC02648
|
FHC02648
|
FNC02648N
|
FNC02648C
|
GATA3 |
GATA binding protein 3, transcript variant 2 |
FXC02784
|
FHC02784
|
FNC02784N
|
FNC02784C
|
SMAD2 |
SMAD family member 2, transcript variant 1 |
FXC03382
|
FHC03382
|
FNC03382N
|
FNC03382C
|
IL23A |
interleukin 23, alpha subunit p19 |
FXC03630
|
FHC03630
|
FNC03630N
|
FNC03630C
|
IFNGR1 |
interferon gamma receptor 1 |
FXC03908
|
FHC03908
|
FNC03908N
|
FNC03908C
|
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
FXC05491
|
FHC05491
|
FNC05491N
|
FNC05491C
|
IL13 |
interleukin 13 |
FXC05505
|
FHC05505
|
FNC05505N
|
FNC05505C
|
IL1A |
interleukin 1, alpha |
FXC05509
|
FHC05509
|
FNC05509N
|
FNC05509C
|
IL1B |
interleukin 1, beta |
FXC05510
|
FHC05510
|
FNC05510N
|
FNC05510C
|
IL2RG |
interleukin 2 receptor, gamma |
FXC05514
|
FHC05514
|
FNC05514N
|
FNC05514C
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A, transcript variant 1 |
FXC06624
|
FHC06624
|
FNC06624N
|
FNC06624C
|
IL10 |
interleukin 10 |
FXC07552
|
FHC07552
|
FNC07552N
|
FNC07552C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 2 |
FXC07774
|
FHC07774
|
FNC07774N
|
FNC07774C
|
IL21R |
interleukin 21 receptor, transcript variant 1 |
FXC08180
|
FHC08180
|
FNC08180N
|
FNC08180C
|
HLA-DMA |
major histocompatibility complex, class II, DM alpha |
FXC08554
|
FHC08554
|
FNC08554N
|
FNC08554C
|
IL6 |
interleukin 6 |
FXC08788
|
FHC08788
|
FNC08788N
|
FNC08788C
|
STAT4 |
signal transducer and activator of transcription 4, transcript variant 1 |
FXC09368
|
FHC09368
|
FNC09368N
|
FNC09368C
|
RORC |
RAR related orphan receptor C, transcript variant 1 |
FXC09376
|
FHC09376
|
FNC09376N
|
FNC09376C
|
TLR2 |
toll-like receptor 2 |
FXC10299
|
FHC10299
|
FNC10299N
|
FNC10299C
|
HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3
|
FXC10549
|
FHC10549
|
|
|
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1, transcript variant 1 |
FXC10550
|
FHC10550
|
FNC10550N
|
FNC10550C
|
IL12A |
interleukin 12A |
FXC10673
|
FHC10673
|
FNC10673N
|
FNC10673C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
NOD2 |
nucleotide-binding oligomerization domain containing 2, transcript variant 1 |
FXC11015
|
FHC11015
|
FNC11015N
|
FNC11015C
|
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
FXC11450
|
FHC11450
|
FNC11450N
|
FNC11450C
|
SLC26A3 |
solute carrier family 26 (anion exchanger), member 3 |
FXC11726
|
FHC11726
|
FNC11726N
|
FNC11726C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 1 |
FXC11986
|
FHC11986
|
FNC11986N
|
FNC11986C
|
TLR4 |
toll-like receptor 4, transcript variant 1 |
FXC12088
|
FHC12088
|
FNC12088N
|
FNC12088C
|
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1, transcript variant 1 |
FXC12349
|
FHC12349
|
FNC12349N
|
FNC12349C
|
IL12RB1 |
interleukin 12 receptor, beta 1, transcript variant 1 |
FXC12558
|
FHC12558
|
FNC12558N
|
FNC12558C
|
TLR5 |
toll-like receptor 5 |
FXC16598
|
FHC16598
|
FNC16598N
|
FNC16598C
|
IL23R |
interleukin 23 receptor |
FXC20351
|
FHC20351
|
FNC20351N
|
FNC20351C
|
IL18R1 |
interleukin 18 receptor 1, transcript variant 1 |
FXC21121
|
FHC21121
|
FNC21121N
|
FNC21121C
|
IL18RAP |
interleukin 18 receptor accessory protein |
FXC21122
|
FHC21122
|
FNC21122N
|
FNC21122C
|
IL21 |
interleukin 21, transcript variant 1 |
FXC22046
|
FHC22046
|
FNC22046N
|
FNC22046C
|
IL12B |
interleukin 12B |
FXC22371
|
FHC22371
|
FNC22371N
|
FNC22371C
|
IL17A |
interleukin 17A |
FXC22655
|
FHC22655
|
FNC22655N
|
FNC22655C
|
IL17F |
interleukin 17F |
FXC22656
|
FHC22656
|
FNC22656N
|
FNC22656C
|
IFNG |
interferon, gamma |
FXC24802
|
FHC24802
|
FNC24802N
|
FNC24802C
|
IL22 |
interleukin 22 |
FXC24804
|
FHC24804
|
FNC24804N
|
FNC24804C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
RORA |
RAR related orphan receptor A, transcript variant 2 |
FXC25414
|
FHC25414
|
FNC25414N
|
FNC25414C
|
RORA |
RAR-related orphan receptor A, transcript variant 4 |
FXC25415
|
FHC25415
|
FNC25415N
|
FNC25415C
|
IL4R |
interleukin 4 receptor, transcript variant 1 |
FXC25645
|
FHC25645
|
FNC25645N
|
FNC25645C
|
TBX21 |
T-box 21 |
FXC26082
|
FHC26082
|
FNC26082N
|
FNC26082C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
RBM45 |
RNA binding motif protein 45 |
FXC28752
|
FHC28752
|
FNC28752N
|
FNC28752C
|
IL18 |
interleukin 18, transcript variant 1 |
FXC30506
|
FHC30506
|
FNC30506N
|
FNC30506C
|
IL2 |
interleukin 2 |
FXC31382
|
FHC31382
|
FNC31382N
|
FNC31382C
|
IL5 |
interleukin 5 |
FXC31397
|
FHC31397
|
FNC31397N
|
FNC31397C
|
IL4 |
interleukin 4, transcript variant 1 |
FXC31398
|
FHC31398
|
FNC31398N
|
FNC31398C
|
C4A |
complement component 4A (Rodgers blood group), transcript variant 1 |
FXC00323
|
FHC00323
|
FNC00323N
|
FNC00323C
|
HIST1H2AC |
histone cluster 1, H2ac |
FXC01399
|
FHC01399
|
FNC01399N
|
FNC01399C
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 2 |
FXC01444
|
FHC01444
|
FNC01444N
|
FNC01444C
|
HNRNPC |
heterogeneous nuclear ribonucleoprotein C (C1/C2), transcript variant 1 |
FXC02140
|
FHC02140
|
FNC02140N
|
FNC02140C
|
HIST1H2BD |
histone cluster 1, H2bd, transcript variant 1 |
FXC02237
|
FHC02237
|
FNC02237N
|
FNC02237C
|
HIST1H3J |
histone cluster 1, H3j |
FXC02310
|
FHC02310
|
FNC02310N
|
FNC02310C
|
HIST1H4K |
histone cluster 1, H4k |
FXC02328
|
FHC02328
|
FNC02328N
|
FNC02328C
|
HIST2H3C |
histone cluster 2, H3c |
FXC02449
|
FHC02449
|
FNC02449N
|
FNC02449C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
H3F3B |
H3 histone, family 3B (H3.3B) |
FXC02611
|
FHC02611
|
FNC02611N
|
FNC02611C
|
SNRPB |
small nuclear ribonucleoprotein polypeptides B and B1, transcript variant 2 |
FXC02710
|
FHC02710
|
FNC02710N
|
FNC02710C
|
SNRPD3 |
small nuclear ribonucleoprotein D3 polypeptide 18kDa, transcript variant 1 |
FXC02860
|
FHC02860
|
FNC02860N
|
FNC02860C
|
H2AFX |
H2A histone family, member X |
FXC02977
|
FHC02977
|
FNC02977N
|
FNC02977C
|
FCGR1A |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
FXC03501
|
FHC03501
|
FNC03501N
|
FNC03501C
|
SSB |
Sjogren syndrome antigen B (autoantigen La), transcript variant 1 |
FXC03583
|
FHC03583
|
FNC03583N
|
FNC03583C
|
TRIM21 |
tripartite motif containing 21 |
FXC03697
|
FHC03697
|
FNC03697N
|
FNC03697C
|
HIST4H4 |
histone cluster 4, H4 |
FXC03890
|
FHC03890
|
FNC03890N
|
FNC03890C
|
C1QC |
complement component 1, q subcomponent, C chain, transcript variant 2 |
FXC04335
|
FHC04335
|
FNC04335N
|
FNC04335C
|
HIST1H4E |
histone cluster 1, H4e |
FXC05389
|
FHC05389
|
FNC05389N
|
FNC05389C
|
HIST1H2AH |
histone cluster 1, H2ah |
FXC05427
|
FHC05427
|
FNC05427N
|
FNC05427C
|
HIST1H2BK |
histone cluster 1, H2bk, transcript variant 2 |
FXC05625
|
FHC05625
|
FNC05625N
|
FNC05625C
|
HIST1H3D |
histone cluster 1, H3d |
FXC05653
|
FHC05653
|
FNC05653N
|
FNC05653C
|
SNRPD1 |
small nuclear ribonucleoprotein D1 polypeptide 16kDa, transcript variant 1 |
FXC06920
|
FHC06920
|
FNC06920N
|
FNC06920C
|
SNRPD2 |
small nuclear ribonucleoprotein D2 polypeptide 16.5kDa, transcript variant 1 |
FXC06921
|
FHC06921
|
FNC06921N
|
FNC06921C
|
IL10 |
interleukin 10 |
FXC07552
|
FHC07552
|
FNC07552N
|
FNC07552C
|
PSMA7 |
proteasome subunit alpha 7 |
FXC08190
|
FHC08190
|
FNC08190N
|
FNC08190C
|
ACTN4 |
actinin, alpha 4 |
FXC08216
|
FHC08216
|
FNC08216N
|
FNC08216C
|
HLA-DMA |
major histocompatibility complex, class II, DM alpha |
FXC08554
|
FHC08554
|
FNC08554N
|
FNC08554C
|
CD40 |
CD40 molecule, TNF receptor superfamily member 5, transcript variant 1 |
FXC08629
|
FHC08629
|
FNC08629N
|
FNC08629C
|
CTSG |
cathepsin G |
FXC08744
|
FHC08744
|
FNC08744N
|
FNC08744C
|
AKR1C1 |
aldo-keto reductase family 1, member C1 |
FXC08783
|
FHC08783
|
FNC08783N
|
FNC08783C
|
ACTN1 |
actinin, alpha 1, transcript variant 2 |
FXC08813
|
FHC08813
|
FNC08813N
|
FNC08813C
|
HIST1H2AG |
histone cluster 1, H2ag |
FXC08853
|
FHC08853
|
FNC08853N
|
FNC08853C
|
H3F3A |
H3 histone, family 3A |
FXC09287
|
FHC09287
|
FNC09287N
|
FNC09287C
|
HIST1H2AM |
histone cluster 1, H2am |
FXC09454
|
FHC09454
|
FNC09454N
|
FNC09454C
|
C6 |
complement component 6, transcript variant 1 |
FXC09582
|
FHC09582
|
FNC09582N
|
FNC09582C
|
TROVE2 |
TROVE domain family, member 2, transcript variant 2 |
FXC09626
|
FHC09626
|
FNC09626N
|
FNC09626C
|
C1QB |
complement component 1, q subcomponent, B chain |
FXC09947
|
FHC09947
|
FNC09947N
|
FNC09947C
|
H2AFZ |
H2A histone family, member Z |
FXC10089
|
FHC10089
|
FNC10089N
|
FNC10089C
|
C9 |
complement component 9 |
FXC10125
|
FHC10125
|
FNC10125N
|
FNC10125C
|
CD86 |
CD86 molecule, transcript variant 1 |
FXC10363
|
FHC10363
|
FNC10363N
|
FNC10363C
|
FCGR3A |
Fc fragment of IgG, low affinity IIIa, receptor (CD16a), transcript variant 1 |
FXC10547
|
FHC10547
|
FNC10547N
|
FNC10547C
|
HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3
|
FXC10549
|
FHC10549
|
|
|
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1, transcript variant 1 |
FXC10550
|
FHC10550
|
FNC10550N
|
FNC10550C
|
HIST1H4B |
histone cluster 1, H4b |
FXC10595
|
FHC10595
|
FNC10595N
|
FNC10595C
|
C1R |
complement component 1, r subcomponent |
FXC10857
|
FHC10857
|
FNC10857N
|
FNC10857C
|
HIST2H2AA3 |
histone cluster 2, H2aa3 |
FXC10911
|
FHC10911
|
FNC10911N
|
FNC10911C
|
HIST1H4D |
histone cluster 1, H4d |
FXC10917
|
FHC10917
|
FNC10917N
|
FNC10917C
|
C7 |
complement component 7 |
FXC10986
|
FHC10986
|
FNC10986N
|
FNC10986C
|
ACTN2 |
actinin, alpha 2, transcript variant 1 |
FXC11021
|
FHC11021
|
FNC11021N
|
FNC11021C
|
C2 |
complement component 2, transcript variant 1 |
FXC11038
|
FHC11038
|
FNC11038N
|
FNC11038C
|
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
FXC11450
|
FHC11450
|
FNC11450N
|
FNC11450C
|
FCGR2A |
Fc fragment of IgG, low affinity IIa, receptor (CD32), transcript variant 2 |
FXC11459
|
FHC11459
|
FNC11459N
|
FNC11459C
|
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
FXC11687
|
FHC11687
|
FNC11687N
|
FNC11687C
|
SLC26A3 |
solute carrier family 26 (anion exchanger), member 3 |
FXC11726
|
FHC11726
|
FNC11726N
|
FNC11726C
|
H2AFY2 |
H2A histone family, member Y2 |
FXC11788
|
FHC11788
|
FNC11788N
|
FNC11788C
|
H2AFY |
H2A histone family, member Y, transcript variant 2 |
FXC12002
|
FHC12002
|
FNC12002N
|
FNC12002C
|
HIST1H3A |
histone cluster 1, H3a |
FXC15886
|
FHC15886
|
FNC15886N
|
FNC15886C
|
C1QA |
complement component 1, q subcomponent, A chain |
FXC20133
|
FHC20133
|
FNC20133N
|
FNC20133C
|
HIST2H2BE |
histone cluster 2, H2be |
FXC20523
|
FHC20523
|
FNC20523N
|
FNC20523C
|
HIST2H2AC |
histone cluster 2, H2ac |
FXC20524
|
FHC20524
|
FNC20524N
|
FNC20524C
|
HIST3H2A |
histone cluster 3, H2a |
FXC20858
|
FHC20858
|
FNC20858N
|
FNC20858C
|
CD28 |
CD28 molecule, transcript variant 1 |
FXC21287
|
FHC21287
|
FNC21287N
|
FNC21287C
|
CD80 |
CD80 molecule |
FXC21656
|
FHC21656
|
FNC21656N
|
FNC21656C
|
HIST1H2BA |
histone cluster 1, H2ba |
FXC22465
|
FHC22465
|
FNC22465N
|
FNC22465C
|
HIST1H4C |
histone cluster 1, H4c |
FXC22484
|
FHC22484
|
FNC22484N
|
FNC22484C
|
HIST1H2BG |
histone cluster 1, H2bg |
FXC22490
|
FHC22490
|
FNC22490N
|
FNC22490C
|
HIST1H2AE |
histone cluster 1, H2ae |
FXC22491
|
FHC22491
|
FNC22491N
|
FNC22491C
|
HIST1H3E |
histone cluster 1, H3e |
FXC22492
|
FHC22492
|
FNC22492N
|
FNC22492C
|
HIST1H3G |
histone cluster 1, H3g |
FXC22497
|
FHC22497
|
FNC22497N
|
FNC22497C
|
HIST1H2BJ |
histone cluster 1, H2bj |
FXC22510
|
FHC22510
|
FNC22510N
|
FNC22510C
|
HIST1H4I |
histone cluster 1, H4i |
FXC22511
|
FHC22511
|
FNC22511N
|
FNC22511C
|
C8G |
complement component 8, gamma polypeptide |
FXC23720
|
FHC23720
|
FNC23720N
|
FNC23720C
|
IFNG |
interferon, gamma |
FXC24802
|
FHC24802
|
FNC24802N
|
FNC24802C
|
CD40LG |
CD40 ligand |
FXC27535
|
FHC27535
|
FNC27535N
|
FNC27535C
|
HIST2H4A |
histone cluster 2, H4a |
FXC27695
|
FHC27695
|
FNC27695N
|
FNC27695C
|
C1S |
complement component 1, s subcomponent, transcript variant 2 |
FXC28104
|
FHC28104
|
FNC28104N
|
FNC28104C
|
RBM45 |
RNA binding motif protein 45 |
FXC28752
|
FHC28752
|
FNC28752N
|
FNC28752C
|
H2BFWT |
H2B histone family, member W, testis-specific |
FXC29462
|
FHC29462
|
FNC29462N
|
FNC29462C
|
C8B |
complement component 8, beta polypeptide, transcript variant 1 |
FXC31629
|
FHC31629
|
FNC31629N
|
FNC31629C
|
C3 |
complement component 3 |
FXC31634
|
FHC31634
|
FNC31634N
|
FNC31634C
|
GPRIN1 |
G protein regulated inducer of neurite outgrowth 1 |
FXC00296
|
FHC00296
|
FNC00296N
|
FNC00296C
|
FASN |
fatty acid synthase |
FXC00314
|
FHC00314
|
FNC00314N
|
FNC00314C
|
NCSTN |
nicastrin, transcript variant 1 |
FXC00480
|
FHC00480
|
FNC00480N
|
FNC00480C
|
LPL |
lipoprotein lipase |
FXC01240
|
FHC01240
|
FNC01240N
|
FNC01240C
|
APP |
amyloid beta (A4) precursor protein, transcript variant 1 |
FXC01278
|
FHC01278
|
FNC01278N
|
FNC01278C
|
ATP2A3 |
ATPase, Ca++ transporting, ubiquitous, transcript variant 1 |
FXC01285
|
FHC01285
|
FNC01285N
|
FNC01285C
|
PSEN1 |
presenilin 1, transcript variant 1 |
FXC01329
|
FHC01329
|
FNC01329N
|
FNC01329C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
CALM3 |
calmodulin 3 (phosphorylase kinase, delta) |
FXC01403
|
FHC01403
|
FNC01403N
|
FNC01403C
|
PPP3CC |
protein phosphatase 3, catalytic subunit, gamma isozyme, transcript variant 2 |
FXC01443
|
FHC01443
|
FNC01443N
|
FNC01443C
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 2 |
FXC01444
|
FHC01444
|
FNC01444N
|
FNC01444C
|
PLCB3 |
phospholipase C, beta 3 (phosphatidylinositol-specific), transcript variant 1 |
FXC01465
|
FHC01465
|
FNC01465N
|
FNC01465C
|
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
FXC01467
|
FHC01467
|
FNC01467N
|
FNC01467C
|
GSK3B |
glycogen synthase kinase 3 beta, transcript variant 2 |
FXC01477
|
FHC01477
|
FNC01477N
|
FNC01477C
|
BID |
BH3 interacting domain death agonist, transcript variant 1 |
FXC01493
|
FHC01493
|
FNC01493N
|
FNC01493C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
FXC01530
|
FHC01530
|
FNC01530N
|
FNC01530C
|
PLCB4 |
phospholipase C, beta 4, transcript variant 2 |
FXC01738
|
FHC01738
|
FNC01738N
|
FNC01738C
|
CAPN1 |
calpain 1, (mu/I) large subunit, transcript variant 2 |
FXC01739
|
FHC01739
|
FNC01739N
|
FNC01739C
|
CAPN2 |
calpain 2, (m/II) large subunit, transcript variant 1 |
FXC01819
|
FHC01819
|
FNC01819N
|
FNC01819C
|
CDK5R1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
FXC01873
|
FHC01873
|
FNC01873N
|
FNC01873C
|
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant 2 |
FXC01927
|
FHC01927
|
FNC01927N
|
FNC01927C
|
PLCB1 |
phospholipase C, beta 1 (phosphoinositide-specific), transcript variant 1 |
FXC01979
|
FHC01979
|
FNC01979N
|
FNC01979C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
ATP5A1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle, transcript variant 2 |
FXC02598
|
FHC02598
|
FNC02598N
|
FNC02598C
|
SNCA |
synuclein, alpha (non A4 component of amyloid precursor), transcript variant 1 |
FXC02635
|
FHC02635
|
FNC02635N
|
FNC02635C
|
CDK5 |
cyclin-dependent kinase 5, transcript variant 1 |
FXC02662
|
FHC02662
|
FNC02662N
|
FNC02662C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase, transcript variant 1 |
FXC02698
|
FHC02698
|
FNC02698N
|
FNC02698C
|
APOE |
apolipoprotein E, transcript variant 2 |
FXC02714
|
FHC02714
|
FNC02714N
|
FNC02714C
|
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
FXC02838
|
FHC02838
|
FNC02838N
|
FNC02838C
|
KCTD14 |
potassium channel tetramerization domain containing 14, transcript variant 2 |
FXC03004
|
FHC03004
|
FNC03004N
|
FNC03004C
|
IDE |
insulin-degrading enzyme, transcript variant 1 |
FXC03818
|
FHC03818
|
FNC03818N
|
FNC03818C
|
PPP3R1 |
protein phosphatase 3, regulatory subunit B, alpha |
FXC03887
|
FHC03887
|
FNC03887N
|
FNC03887C
|
APAF1 |
apoptotic peptidase activating factor 1, transcript variant 1 |
FXC04119
|
FHC04119
|
FNC04119N
|
FNC04119C
|
APH1B |
APH1B gamma secretase subunit, transcript variant 1 |
FXC04124
|
FHC04124
|
FNC04124N
|
FNC04124C
|
ATP5G1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9), transcript variant 1 |
FXC04215
|
FHC04215
|
FNC04215N
|
FNC04215C
|
COX5B |
cytochrome c oxidase subunit Vb |
FXC04615
|
FHC04615
|
FNC04615N
|
FNC04615C
|
FAS |
Fas cell surface death receptor |
FXC04988
|
FHC04988
|
FNC04988N
|
FNC04988C
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
FXC05358
|
FHC05358
|
FNC05358N
|
FNC05358C
|
IL1B |
interleukin 1, beta |
FXC05510
|
FHC05510
|
FNC05510N
|
FNC05510C
|
NDUFB1 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa |
FXC06127
|
FHC06127
|
FNC06127N
|
FNC06127C
|
NDUFB9 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa, transcript variant 1 |
FXC06128
|
FHC06128
|
FNC06128N
|
FNC06128C
|
CYCS |
cytochrome c, somatic |
FXC07778
|
FHC07778
|
FNC07778N
|
FNC07778C
|
PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme, transcript variant 2 |
FXC07780
|
FHC07780
|
FNC07780N
|
FNC07780C
|
ATP5B |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
FXC07782
|
FHC07782
|
FNC07782N
|
FNC07782C
|
COX6C |
cytochrome c oxidase subunit VIc |
FXC07836
|
FHC07836
|
FNC07836N
|
FNC07836C
|
NAE1 |
NEDD8 activating enzyme E1 subunit 1, transcript variant 1 |
FXC07868
|
FHC07868
|
FNC07868N
|
FNC07868C
|
UQCRC2 |
ubiquinol-cytochrome c reductase core protein II |
FXC07872
|
FHC07872
|
FNC07872N
|
FNC07872C
|
UQCRFS1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
FXC07903
|
FHC07903
|
FNC07903N
|
FNC07903C
|
NDUFV2 |
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
FXC08018
|
FHC08018
|
FNC08018N
|
FNC08018C
|
CASP9 |
caspase 9, transcript variant alpha |
FXC08062
|
FHC08062
|
FNC08062N
|
FNC08062C
|
NDUFA10 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa |
FXC08150
|
FHC08150
|
FNC08150N
|
FNC08150C
|
SDHD |
succinate dehydrogenase complex, subunit D, integral membrane protein, transcript variant 1 |
FXC08233
|
FHC08233
|
FNC08233N
|
FNC08233C
|
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
FXC08338
|
FHC08338
|
FNC08338N
|
FNC08338C
|
COX6A1 |
cytochrome c oxidase subunit VIa polypeptide 1 |
FXC08343
|
FHC08343
|
FNC08343N
|
FNC08343C
|
PSENEN |
presenilin enhancer gamma secretase subunit, transcript variant 1 |
FXC08437
|
FHC08437
|
FNC08437N
|
FNC08437C
|
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
FXC08484
|
FHC08484
|
FNC08484N
|
FNC08484C
|
APBB1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65), transcript variant 2 |
FXC08522
|
FHC08522
|
FNC08522N
|
FNC08522C
|
BACE2 |
beta-site APP-cleaving enzyme 2, transcript variant a |
FXC08743
|
FHC08743
|
FNC08743N
|
FNC08743C
|
NDUFV1 |
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa, transcript variant 1 |
FXC08801
|
FHC08801
|
FNC08801N
|
FNC08801C
|
CASP3 |
caspase 3, apoptosis-related cysteine peptidase, transcript variant alpha |
FXC08865
|
FHC08865
|
FNC08865N
|
FNC08865C
|
NDUFB3 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa, transcript variant 1 |
FXC08953
|
FHC08953
|
FNC08953N
|
FNC08953C
|
COX7B |
cytochrome c oxidase subunit VIIb |
FXC08960
|
FHC08960
|
FNC08960N
|
FNC08960C
|
CYC1 |
cytochrome c-1 |
FXC09013
|
FHC09013
|
FNC09013N
|
FNC09013C
|
ATP5G2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) |
FXC09037
|
FHC09037
|
FNC09037N
|
FNC09037C
|
COX5A |
cytochrome c oxidase subunit Va |
FXC09137
|
FHC09137
|
FNC09137N
|
FNC09137C
|
COX6A2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
FXC09312
|
FHC09312
|
FNC09312N
|
FNC09312C
|
CALML3 |
calmodulin-like 3 |
FXC09388
|
FHC09388
|
FNC09388N
|
FNC09388C
|
NDUFA6 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa |
FXC09677
|
FHC09677
|
FNC09677N
|
FNC09677C
|
NDUFS2 |
NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC09693
|
FHC09693
|
FNC09693N
|
FNC09693C
|
FADD |
Fas (TNFRSF6)-associated via death domain |
FXC09707
|
FHC09707
|
FNC09707N
|
FNC09707C
|
NDUFS3 |
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) |
FXC09729
|
FHC09729
|
FNC09729N
|
FNC09729C
|
COX6B1 |
cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) |
FXC09747
|
FHC09747
|
FNC09747N
|
FNC09747C
|
COX7A2L |
cytochrome c oxidase subunit VIIa polypeptide 2 like |
FXC09862
|
FHC09862
|
FNC09862N
|
FNC09862C
|
PSEN2 |
presenilin 2, transcript variant 1 |
FXC09882
|
FHC09882
|
FNC09882N
|
FNC09882C
|
CASP7 |
caspase 7, apoptosis-related cysteine peptidase, transcript variant a |
FXC10056
|
FHC10056
|
FNC10056N
|
FNC10056C
|
PTGS1 |
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase), transcript variant 1 |
FXC10242
|
FHC10242
|
FNC10242N
|
FNC10242C
|
NDUFA13 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 |
FXC10634
|
FHC10634
|
FNC10634N
|
FNC10634C
|
ATP2A1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1, transcript variant b |
FXC10728
|
FHC10728
|
FNC10728N
|
FNC10728C
|
NDUFC2 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa, transcript variant 1 |
FXC10813
|
FHC10813
|
FNC10813N
|
FNC10813C
|
MMP12 |
matrix metallopeptidase 12 |
FXC10970
|
FHC10970
|
FNC10970N
|
FNC10970C
|
BACE1 |
beta-site APP-cleaving enzyme 1, transcript variant a |
FXC10981
|
FHC10981
|
FNC10981N
|
FNC10981C
|
ATP5C1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1, transcript variant 1 |
FXC11490
|
FHC11490
|
FNC11490N
|
FNC11490C
|
SDHA |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp), transcript variant 1 |
FXC11617
|
FHC11617
|
FNC11617N
|
FNC11617C
|
MAPT |
microtubule-associated protein tau, transcript variant 4 |
FXC11766
|
FHC11766
|
FNC11766N
|
FNC11766C
|
CALM2 |
calmodulin 2 (phosphorylase kinase, delta), transcript variant 2 |
FXC11793
|
FHC11793
|
FNC11793N
|
FNC11793C
|
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2, transcript variant b |
FXC11825
|
FHC11825
|
FNC11825N
|
FNC11825C
|
COX7C |
cytochrome c oxidase subunit VIIc |
FXC11906
|
FHC11906
|
FNC11906N
|
FNC11906C
|
ITPR3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
FXC12472
|
FHC12472
|
FNC12472N
|
FNC12472C
|
CASP8 |
caspase 8, apoptosis-related cysteine peptidase, transcript variant G |
FXC12541
|
FHC12541
|
FNC12541N
|
FNC12541C
|
COX4I1 |
cytochrome c oxidase subunit IV isoform 1 |
FXC13106
|
FHC13106
|
FNC13106N
|
FNC13106C
|
COX7A2 |
cytochrome c oxidase subunit VIIa polypeptide 2 (liver) |
FXC13423
|
FHC13423
|
FNC13423N
|
FNC13423C
|
ADAM17 |
ADAM metallopeptidase domain 17 |
FXC14599
|
FHC14599
|
|
|
NDUFV3 |
NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa, transcript variant 2 |
FXC14706
|
FHC14706
|
FNC14706N
|
FNC14706C
|
LRP1 |
low density lipoprotein receptor-related protein 1 |
FXC15907
|
FHC15907
|
FNC15907N
|
FNC15907C
|
ATP5E |
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
FXC16614
|
FHC16614
|
FNC16614N
|
FNC16614C
|
NDUFS5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC20237
|
FHC20237
|
FNC20237N
|
FNC20237C
|
ATP5F1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 |
FXC20471
|
FHC20471
|
FNC20471N
|
FNC20471C
|
SDHC |
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa, transcript variant 1 |
FXC20677
|
FHC20677
|
FNC20677N
|
FNC20677C
|
ATF6 |
activating transcription factor 6 |
FXC20682
|
FHC20682
|
FNC20682N
|
FNC20682C
|
ATP5G3 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9), transcript variant 2 |
FXC21233
|
FHC21233
|
FNC21233N
|
FNC21233C
|
NDUFS1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC21290
|
FHC21290
|
FNC21290N
|
FNC21290C
|
UQCRC1 |
ubiquinol-cytochrome c reductase core protein I |
FXC21528
|
FHC21528
|
FNC21528N
|
FNC21528C
|
COX7B2 |
cytochrome c oxidase subunit VIIb2 |
FXC21906
|
FHC21906
|
FNC21906N
|
FNC21906C
|
NDUFS6 |
NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) |
FXC22122
|
FHC22122
|
FNC22122N
|
FNC22122C
|
NDUFS4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) |
FXC22169
|
FHC22169
|
FNC22169N
|
FNC22169C
|
UQCRB |
ubiquinol-cytochrome c reductase binding protein, transcript variant 1 |
FXC23350
|
FHC23350
|
FNC23350N
|
FNC23350C
|
NDUFB6 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa, transcript variant 1 |
FXC23492
|
FHC23492
|
FNC23492N
|
FNC23492C
|
CALML5 |
calmodulin-like 5 |
FXC23748
|
FHC23748
|
FNC23748N
|
FNC23748C
|
NANOS1 |
nanos homolog 1 (Drosophila) |
FXC24034
|
FHC24034
|
FNC24034N
|
FNC24034C
|
COX8A |
cytochrome c oxidase subunit VIIIA (ubiquitous) |
FXC24280
|
FHC24280
|
FNC24280N
|
FNC24280C
|
NDUFA12 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12, transcript variant 1 |
FXC24832
|
FHC24832
|
FNC24832N
|
FNC24832C
|
COX8C |
cytochrome c oxidase subunit VIIIC |
FXC25279
|
FHC25279
|
FNC25279N
|
FNC25279C
|
ADAM10 |
ADAM metallopeptidase domain 10 |
FXC25405
|
FHC25405
|
FNC25405N
|
FNC25405C
|
ATP5H |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d, transcript variant 1 |
FXC26184
|
FHC26184
|
FNC26184N
|
FNC26184C
|
ATP5D |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit, transcript variant 1 |
FXC26369
|
FHC26369
|
FNC26369N
|
FNC26369C
|
GRIN2D |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
FXC26720
|
FHC26720
|
FNC26720N
|
FNC26720C
|
ATP5J |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6, transcript variant 2 |
FXC27126
|
FHC27126
|
FNC27126N
|
FNC27126C
|
ATP5O |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit
|
FXC27161
|
FHC27161
|
|
|
NDUFA1 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa |
FXC27495
|
FHC27495
|
FNC27495N
|
FNC27495C
|
UQCRH |
ubiquinol-cytochrome c reductase hinge protein, transcript variant 1 |
FXC27655
|
FHC27655
|
FNC27655N
|
FNC27655C
|
UQCRQ |
ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa |
FXC29084
|
FHC29084
|
FNC29084N
|
FNC29084C
|
CACNA1F |
calcium channel, voltage-dependent, L type, alpha 1F subunit, transcript variant 1 |
FXC29434
|
FHC29434
|
FNC29434N
|
FNC29434C
|
APH1A |
APH1A gamma secretase subunit, transcript variant 2 |
FXC29569
|
FHC29569
|
FNC29569N
|
FNC29569C
|
UQCR10 |
ubiquinol-cytochrome c reductase, complex III subunit X, transcript variant 1 |
FXC30961
|
FHC30961
|
FNC30961N
|
FNC30961C
|
C1D |
C1D nuclear receptor corepressor, transcript variant 1 |
FXC31357
|
FHC31357
|
FNC31357N
|
FNC31357C
|
NOS1 |
nitric oxide synthase 1 (neuronal), transcript variant 1
|
FXC31690
|
FHC31690
|
|
|
DRD1 |
dopamine receptor D1 |
FXC00007
|
FHC00007
|
FNC00007N
|
FNC00007C
|
IVNS1ABP |
influenza virus NS1A binding protein |
FXC00137
|
FHC00137
|
FNC00137N
|
FNC00137C
|
PINK1 |
PTEN induced putative kinase 1 |
FXC01021
|
FHC01021
|
FNC01021N
|
FNC01021C
|
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1, transcript variant 1 |
FXC01301
|
FHC01301
|
FNC01301N
|
FNC01301C
|
UBA1 |
ubiquitin-like modifier activating enzyme 1, transcript variant 1 |
FXC01370
|
FHC01370
|
FNC01370N
|
FNC01370C
|
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
FXC01467
|
FHC01467
|
FNC01467N
|
FNC01467C
|
DRD2 |
dopamine receptor D2, transcript variant 1 |
FXC01519
|
FHC01519
|
FNC01519N
|
FNC01519C
|
PLXNB1 |
plexin B1, transcript variant 1 |
FXC01666
|
FHC01666
|
FNC01666N
|
FNC01666C
|
GPR37 |
G protein-coupled receptor 37 (endothelin receptor type B-like) |
FXC02234
|
FHC02234
|
FNC02234N
|
FNC02234C
|
ATP5A1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle, transcript variant 2 |
FXC02598
|
FHC02598
|
FNC02598N
|
FNC02598C
|
SNCA |
synuclein, alpha (non A4 component of amyloid precursor), transcript variant 1 |
FXC02635
|
FHC02635
|
FNC02635N
|
FNC02635C
|
HTRA2 |
HtrA serine peptidase 2, transcript variant 1 |
FXC02652
|
FHC02652
|
FNC02652N
|
FNC02652C
|
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta, transcript variant 3 |
FXC02835
|
FHC02835
|
FNC02835N
|
FNC02835C
|
KCTD14 |
potassium channel tetramerization domain containing 14, transcript variant 2 |
FXC03004
|
FHC03004
|
FNC03004N
|
FNC03004C
|
PRKCA |
protein kinase C, alpha |
FXC03611
|
FHC03611
|
FNC03611N
|
FNC03611C
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
FXC03780
|
FHC03780
|
FNC03780N
|
FNC03780C
|
PARK2 |
parkin RBR E3 ubiquitin protein ligase, transcript variant 1 |
FXC03885
|
FHC03885
|
FNC03885N
|
FNC03885C
|
ADORA2A |
adenosine A2a receptor, transcript variant 3 |
FXC04058
|
FHC04058
|
FNC04058N
|
FNC04058C
|
APAF1 |
apoptotic peptidase activating factor 1, transcript variant 1 |
FXC04119
|
FHC04119
|
FNC04119N
|
FNC04119C
|
ATP5G1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9), transcript variant 1 |
FXC04215
|
FHC04215
|
FNC04215N
|
FNC04215C
|
COX5B |
cytochrome c oxidase subunit Vb |
FXC04615
|
FHC04615
|
FNC04615N
|
FNC04615C
|
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2, transcript variant 1 |
FXC05310
|
FHC05310
|
FNC05310N
|
FNC05310C
|
GNAI3 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
FXC05311
|
FHC05311
|
FNC05311N
|
FNC05311C
|
NDUFB1 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa |
FXC06127
|
FHC06127
|
FNC06127N
|
FNC06127C
|
NDUFB9 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa, transcript variant 1 |
FXC06128
|
FHC06128
|
FNC06128N
|
FNC06128C
|
PARK7 |
parkinson protein 7, transcript variant 1 |
FXC06271
|
FHC06271
|
FNC06271N
|
FNC06271C
|
PRKACG |
protein kinase, cAMP-dependent, catalytic, gamma |
FXC06481
|
FHC06481
|
FNC06481N
|
FNC06481C
|
SLC25A4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
FXC06856
|
FHC06856
|
FNC06856N
|
FNC06856C
|
UBE2J1 |
ubiquitin-conjugating enzyme E2, J1 |
FXC07265
|
FHC07265
|
FNC07265N
|
FNC07265C
|
UBE2L3 |
ubiquitin-conjugating enzyme E2L 3, transcript variant 1 |
FXC07267
|
FHC07267
|
FNC07267N
|
FNC07267C
|
CYCS |
cytochrome c, somatic |
FXC07778
|
FHC07778
|
FNC07778N
|
FNC07778C
|
ATP5B |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
FXC07782
|
FHC07782
|
FNC07782N
|
FNC07782C
|
SLC25A31 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 |
FXC07801
|
FHC07801
|
FNC07801N
|
FNC07801C
|
COX6C |
cytochrome c oxidase subunit VIc |
FXC07836
|
FHC07836
|
FNC07836N
|
FNC07836C
|
UCHL1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
FXC07850
|
FHC07850
|
FNC07850N
|
FNC07850C
|
UQCRC2 |
ubiquinol-cytochrome c reductase core protein II |
FXC07872
|
FHC07872
|
FNC07872N
|
FNC07872C
|
UQCRFS1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
FXC07903
|
FHC07903
|
FNC07903N
|
FNC07903C
|
NDUFV2 |
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
FXC08018
|
FHC08018
|
FNC08018N
|
FNC08018C
|
CASP9 |
caspase 9, transcript variant alpha |
FXC08062
|
FHC08062
|
FNC08062N
|
FNC08062C
|
NDUFA10 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa |
FXC08150
|
FHC08150
|
FNC08150N
|
FNC08150C
|
SDHD |
succinate dehydrogenase complex, subunit D, integral membrane protein, transcript variant 1 |
FXC08233
|
FHC08233
|
FNC08233N
|
FNC08233C
|
COX6A1 |
cytochrome c oxidase subunit VIa polypeptide 1 |
FXC08343
|
FHC08343
|
FNC08343N
|
FNC08343C
|
NDUFV1 |
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa, transcript variant 1 |
FXC08801
|
FHC08801
|
FNC08801N
|
FNC08801C
|
CASP3 |
caspase 3, apoptosis-related cysteine peptidase, transcript variant alpha |
FXC08865
|
FHC08865
|
FNC08865N
|
FNC08865C
|
NDUFB3 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa, transcript variant 1 |
FXC08953
|
FHC08953
|
FNC08953N
|
FNC08953C
|
COX7B |
cytochrome c oxidase subunit VIIb |
FXC08960
|
FHC08960
|
FNC08960N
|
FNC08960C
|
CYC1 |
cytochrome c-1 |
FXC09013
|
FHC09013
|
FNC09013N
|
FNC09013C
|
ATP5G2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) |
FXC09037
|
FHC09037
|
FNC09037N
|
FNC09037C
|
COX5A |
cytochrome c oxidase subunit Va |
FXC09137
|
FHC09137
|
FNC09137N
|
FNC09137C
|
COX6A2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
FXC09312
|
FHC09312
|
FNC09312N
|
FNC09312C
|
NDUFA6 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa |
FXC09677
|
FHC09677
|
FNC09677N
|
FNC09677C
|
NDUFS2 |
NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC09693
|
FHC09693
|
FNC09693N
|
FNC09693C
|
NDUFS3 |
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) |
FXC09729
|
FHC09729
|
FNC09729N
|
FNC09729C
|
COX6B1 |
cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) |
FXC09747
|
FHC09747
|
FNC09747N
|
FNC09747C
|
COX7A2L |
cytochrome c oxidase subunit VIIa polypeptide 2 like |
FXC09862
|
FHC09862
|
FNC09862N
|
FNC09862C
|
VDAC1 |
voltage-dependent anion channel 1, transcript variant 1 |
FXC09931
|
FHC09931
|
FNC09931N
|
FNC09931C
|
PTGS1 |
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase), transcript variant 1 |
FXC10242
|
FHC10242
|
FNC10242N
|
FNC10242C
|
UBE2L6 |
ubiquitin-conjugating enzyme E2L 6, transcript variant 1 |
FXC10288
|
FHC10288
|
FNC10288N
|
FNC10288C
|
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha, transcript variant 1 |
FXC10564
|
FHC10564
|
FNC10564N
|
FNC10564C
|
NDUFA13 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 |
FXC10634
|
FHC10634
|
FNC10634N
|
FNC10634C
|
ADCY5 |
adenylate cyclase 5, transcript variant 1 |
FXC10764
|
FHC10764
|
FNC10764N
|
FNC10764C
|
NDUFC2 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa, transcript variant 1 |
FXC10813
|
FHC10813
|
FNC10813N
|
FNC10813C
|
UBA7 |
ubiquitin-like modifier activating enzyme 7 |
FXC11051
|
FHC11051
|
FNC11051N
|
FNC11051C
|
ATP5C1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1, transcript variant 1 |
FXC11490
|
FHC11490
|
FNC11490N
|
FNC11490C
|
PPIF |
peptidylprolyl isomerase F |
FXC11591
|
FHC11591
|
FNC11591N
|
FNC11591C
|
SDHA |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp), transcript variant 1 |
FXC11617
|
FHC11617
|
FNC11617N
|
FNC11617C
|
COX7C |
cytochrome c oxidase subunit VIIc |
FXC11906
|
FHC11906
|
FNC11906N
|
FNC11906C
|
COX4I1 |
cytochrome c oxidase subunit IV isoform 1 |
FXC13106
|
FHC13106
|
FNC13106N
|
FNC13106C
|
COX7A2 |
cytochrome c oxidase subunit VIIa polypeptide 2 (liver) |
FXC13423
|
FHC13423
|
FNC13423N
|
FNC13423C
|
SLC18A1 |
solute carrier family 18 (vesicular monoamine transporter), member 1 |
FXC14030
|
FHC14030
|
FNC14030N
|
FNC14030C
|
NDUFV3 |
NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa, transcript variant 2 |
FXC14706
|
FHC14706
|
FNC14706N
|
FNC14706C
|
SLC25A6 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 |
FXC14765
|
FHC14765
|
FNC14765N
|
FNC14765C
|
VDAC2 |
voltage-dependent anion channel 2, transcript variant 2 |
FXC14809
|
FHC14809
|
FNC14809N
|
FNC14809C
|
ATP5E |
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
FXC16614
|
FHC16614
|
FNC16614N
|
FNC16614C
|
UBE2J2 |
ubiquitin-conjugating enzyme E2, J2, transcript variant 2 |
FXC20012
|
FHC20012
|
FNC20012N
|
FNC20012C
|
NDUFS5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC20237
|
FHC20237
|
FNC20237N
|
FNC20237C
|
ATP5F1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 |
FXC20471
|
FHC20471
|
FNC20471N
|
FNC20471C
|
SDHC |
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa, transcript variant 1 |
FXC20677
|
FHC20677
|
FNC20677N
|
FNC20677C
|
ATP5G3 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9), transcript variant 2 |
FXC21233
|
FHC21233
|
FNC21233N
|
FNC21233C
|
NDUFS1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC21290
|
FHC21290
|
FNC21290N
|
FNC21290C
|
UQCRC1 |
ubiquinol-cytochrome c reductase core protein I |
FXC21528
|
FHC21528
|
FNC21528N
|
FNC21528C
|
COX7B2 |
cytochrome c oxidase subunit VIIb2 |
FXC21906
|
FHC21906
|
FNC21906N
|
FNC21906C
|
NDUFS6 |
NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) |
FXC22122
|
FHC22122
|
FNC22122N
|
FNC22122C
|
NDUFS4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) |
FXC22169
|
FHC22169
|
FNC22169N
|
FNC22169C
|
VDAC3 |
voltage-dependent anion channel 3, transcript variant 1 |
FXC23255
|
FHC23255
|
FNC23255N
|
FNC23255C
|
UQCRB |
ubiquinol-cytochrome c reductase binding protein, transcript variant 1 |
FXC23350
|
FHC23350
|
FNC23350N
|
FNC23350C
|
NDUFB6 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa, transcript variant 1 |
FXC23492
|
FHC23492
|
FNC23492N
|
FNC23492C
|
COX8A |
cytochrome c oxidase subunit VIIIA (ubiquitous) |
FXC24280
|
FHC24280
|
FNC24280N
|
FNC24280C
|
NDUFA12 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12, transcript variant 1 |
FXC24832
|
FHC24832
|
FNC24832N
|
FNC24832C
|
COX8C |
cytochrome c oxidase subunit VIIIC |
FXC25279
|
FHC25279
|
FNC25279N
|
FNC25279C
|
ATP5H |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d, transcript variant 1 |
FXC26184
|
FHC26184
|
FNC26184N
|
FNC26184C
|
GNAL |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type, transcript variant 1 |
FXC26254
|
FHC26254
|
FNC26254N
|
FNC26254C
|
ATP5D |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit, transcript variant 1 |
FXC26369
|
FHC26369
|
FNC26369N
|
FNC26369C
|
ATP5J |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6, transcript variant 2 |
FXC27126
|
FHC27126
|
FNC27126N
|
FNC27126C
|
ATP5O |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit
|
FXC27161
|
FHC27161
|
|
|
UBE2G2 |
ubiquitin-conjugating enzyme E2G 2, transcript variant 1 |
FXC27206
|
FHC27206
|
FNC27206N
|
FNC27206C
|
SLC25A5 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
FXC27491
|
FHC27491
|
FNC27491N
|
FNC27491C
|
NDUFA1 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa |
FXC27495
|
FHC27495
|
FNC27495N
|
FNC27495C
|
UQCRH |
ubiquinol-cytochrome c reductase hinge protein, transcript variant 1 |
FXC27655
|
FHC27655
|
FNC27655N
|
FNC27655C
|
LRRK2 |
leucine-rich repeat kinase 2 |
FXC28124
|
FHC28124
|
|
|
UBE2G1 |
ubiquitin-conjugating enzyme E2G 1 |
FXC28418
|
FHC28418
|
FNC28418N
|
FNC28418C
|
UQCRQ |
ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa |
FXC29084
|
FHC29084
|
FNC29084N
|
FNC29084C
|
UQCR10 |
ubiquinol-cytochrome c reductase, complex III subunit X, transcript variant 1 |
FXC30961
|
FHC30961
|
FNC30961N
|
FNC30961C
|
TH |
tyrosine hydroxylase, transcript variant 3 |
FXC31463
|
FHC31463
|
FNC31463N
|
FNC31463C
|
UBB |
ubiquitin B, transcript variant 1 |
FXC31552
|
FHC31552
|
FNC31552N
|
FNC31552C
|
AP2M1 |
adaptor-related protein complex 2, mu 1 subunit, transcript variant 1 |
FXC00018
|
FHC00018
|
FNC00018N
|
FNC00018C
|
GPRIN1 |
G protein regulated inducer of neurite outgrowth 1 |
FXC00296
|
FHC00296
|
FNC00296N
|
FNC00296C
|
CREB1 |
cAMP responsive element binding protein 1, transcript variant B |
FXC00339
|
FHC00339
|
FNC00339N
|
FNC00339C
|
AP2A2 |
adaptor-related protein complex 2, alpha 2 subunit, transcript variant 2 |
FXC00678
|
FHC00678
|
FNC00678N
|
FNC00678C
|
DNAH1 |
dynein, axonemal, heavy chain 1
|
FXC00827
|
FHC00827
|
|
|
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
NFE2L1 |
nuclear factor, erythroid 2-like 1 |
FXC01045
|
FHC01045
|
FNC01045N
|
FNC01045C
|
POLR2B |
polymerase (RNA) II (DNA directed) polypeptide B, 140kDa, transcript variant 1 |
FXC01314
|
FHC01314
|
FNC01314N
|
FNC01314C
|
AP2B1 |
adaptor-related protein complex 2, beta 1 subunit, transcript variant 2 |
FXC01387
|
FHC01387
|
FNC01387N
|
FNC01387C
|
POLR2J3 |
polymerase (RNA) II (DNA directed) polypeptide J3 |
FXC01391
|
FHC01391
|
FNC01391N
|
FNC01391C
|
DLG4 |
discs, large homolog 4 (Drosophila), transcript variant 2 |
FXC01457
|
FHC01457
|
FNC01457N
|
FNC01457C
|
PLCB3 |
phospholipase C, beta 3 (phosphatidylinositol-specific), transcript variant 1 |
FXC01465
|
FHC01465
|
FNC01465N
|
FNC01465C
|
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
FXC01467
|
FHC01467
|
FNC01467N
|
FNC01467C
|
DNAH2 |
dynein, axonemal, heavy chain 2 |
FXC01692
|
FHC01692
|
FNC01692N
|
FNC01692C
|
PLCB4 |
phospholipase C, beta 4, transcript variant 2 |
FXC01738
|
FHC01738
|
FNC01738N
|
FNC01738C
|
EP300 |
E1A binding protein p300 |
FXC01787
|
FHC01787
|
FNC01787N
|
FNC01787C
|
REST |
RE1-silencing transcription factor, transcript variant 1 |
FXC01798
|
FHC01798
|
FNC01798N
|
FNC01798C
|
HIP1 |
huntingtin interacting protein 1, transcript variant 1 |
FXC01887
|
FHC01887
|
FNC01887N
|
FNC01887C
|
PLCB1 |
phospholipase C, beta 1 (phosphoinositide-specific), transcript variant 1 |
FXC01979
|
FHC01979
|
FNC01979N
|
FNC01979C
|
DNAH7 |
dynein, axonemal, heavy chain 7 |
FXC02006
|
FHC02006
|
FNC02006N
|
FNC02006C
|
DNAH2 |
dynein, axonemal, heavy chain 2, transcript variant 1 |
FXC02065
|
FHC02065
|
FNC02065N
|
FNC02065C
|
TBPL1 |
TBP-like 1, transcript variant 2 |
FXC02081
|
FHC02081
|
FNC02081N
|
FNC02081C
|
HAP1 |
huntingtin-associated protein 1, transcript variant 4 |
FXC02110
|
FHC02110
|
FNC02110N
|
FNC02110C
|
POLR2C |
polymerase (RNA) II (DNA directed) polypeptide C, 33kDa |
FXC02184
|
FHC02184
|
FNC02184N
|
FNC02184C
|
RCOR1 |
REST corepressor 1 |
FXC02300
|
FHC02300
|
FNC02300N
|
FNC02300C
|
POLR2K |
polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa |
FXC02479
|
FHC02479
|
FNC02479N
|
FNC02479C
|
POLR2I |
polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa |
FXC02488
|
FHC02488
|
FNC02488N
|
FNC02488C
|
TFAM |
transcription factor A, mitochondrial, transcript variant 1 |
FXC02491
|
FHC02491
|
FNC02491N
|
FNC02491C
|
POLR2H |
polymerase (RNA) II (DNA directed) polypeptide H, transcript variant 2 |
FXC02496
|
FHC02496
|
FNC02496N
|
FNC02496C
|
POLR2G |
polymerase (RNA) II (DNA directed) polypeptide G |
FXC02500
|
FHC02500
|
FNC02500N
|
FNC02500C
|
CREB3 |
cAMP responsive element binding protein 3 |
FXC02549
|
FHC02549
|
FNC02549N
|
FNC02549C
|
HDAC1 |
histone deacetylase 1 |
FXC02563
|
FHC02563
|
FNC02563N
|
FNC02563C
|
ATP5A1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle, transcript variant 2 |
FXC02598
|
FHC02598
|
FNC02598N
|
FNC02598C
|
SOD1 |
superoxide dismutase 1, soluble |
FXC02668
|
FHC02668
|
FNC02668N
|
FNC02668C
|
CLTA |
clathrin, light chain A, transcript variant 2 |
FXC02674
|
FHC02674
|
FNC02674N
|
FNC02674C
|
POLR2E |
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa |
FXC02707
|
FHC02707
|
FNC02707N
|
FNC02707C
|
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
FXC02838
|
FHC02838
|
FNC02838N
|
FNC02838C
|
KCTD14 |
potassium channel tetramerization domain containing 14, transcript variant 2 |
FXC03004
|
FHC03004
|
FNC03004N
|
FNC03004C
|
POLR2L |
polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa |
FXC03064
|
FHC03064
|
FNC03064N
|
FNC03064C
|
POLR2F |
polymerase (RNA) II (DNA directed) polypeptide F, transcript variant 1 |
FXC03155
|
FHC03155
|
FNC03155N
|
FNC03155C
|
BDNF |
brain-derived neurotrophic factor, transcript variant 4 |
FXC03322
|
FHC03322
|
FNC03322N
|
FNC03322C
|
TAF4B |
TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa, transcript variant 2 |
FXC03662
|
FHC03662
|
FNC03662N
|
FNC03662C
|
CREB3L4 |
cAMP responsive element binding protein 3-like 4, transcript variant 1 |
FXC03678
|
FHC03678
|
FNC03678N
|
FNC03678C
|
AP2A1 |
adaptor-related protein complex 2, alpha 1 subunit, transcript variant 2 |
FXC03782
|
FHC03782
|
FNC03782N
|
FNC03782C
|
APAF1 |
apoptotic peptidase activating factor 1, transcript variant 1 |
FXC04119
|
FHC04119
|
FNC04119N
|
FNC04119C
|
APEX1 |
APEX nuclease (multifunctional DNA repair enzyme) 1, transcript variant 1 |
FXC04122
|
FHC04122
|
FNC04122N
|
FNC04122C
|
ATP5G1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9), transcript variant 1 |
FXC04215
|
FHC04215
|
FNC04215N
|
FNC04215C
|
CLTC |
clathrin, heavy chain (Hc), transcript variant 1 |
FXC04587
|
FHC04587
|
FNC04587N
|
FNC04587C
|
COX5B |
cytochrome c oxidase subunit Vb |
FXC04615
|
FHC04615
|
FNC04615N
|
FNC04615C
|
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
FXC04624
|
FHC04624
|
FNC04624N
|
FNC04624C
|
CREB3L2 |
cAMP responsive element binding protein 3-like 2, transcript variant 1 |
FXC04625
|
FHC04625
|
FNC04625N
|
FNC04625C
|
HDAC2 |
histone deacetylase 2 |
FXC05328
|
FHC05328
|
FNC05328N
|
FNC05328C
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
FXC05358
|
FHC05358
|
FNC05358N
|
FNC05358C
|
NDUFB1 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa |
FXC06127
|
FHC06127
|
FNC06127N
|
FNC06127C
|
NDUFB9 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa, transcript variant 1 |
FXC06128
|
FHC06128
|
FNC06128N
|
FNC06128C
|
NRF1 |
nuclear respiratory factor 1, transcript variant 1 |
FXC06193
|
FHC06193
|
FNC06193N
|
FNC06193C
|
POLR2D |
polymerase (RNA) II (DNA directed) polypeptide D |
FXC06425
|
FHC06425
|
FNC06425N
|
FNC06425C
|
PSG1 |
pregnancy specific beta-1-glycoprotein 1, transcript variant 2 |
FXC06508
|
FHC06508
|
FNC06508N
|
FNC06508C
|
SLC25A4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
FXC06856
|
FHC06856
|
FNC06856N
|
FNC06856C
|
SP1 |
Sp1 transcription factor, transcript variant 1 |
FXC07743
|
FHC07743
|
FNC07743N
|
FNC07743C
|
CYCS |
cytochrome c, somatic |
FXC07778
|
FHC07778
|
FNC07778N
|
FNC07778C
|
ATP5B |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
FXC07782
|
FHC07782
|
FNC07782N
|
FNC07782C
|
SLC25A31 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 |
FXC07801
|
FHC07801
|
FNC07801N
|
FNC07801C
|
COX6C |
cytochrome c oxidase subunit VIc |
FXC07836
|
FHC07836
|
FNC07836N
|
FNC07836C
|
UQCRC2 |
ubiquinol-cytochrome c reductase core protein II |
FXC07872
|
FHC07872
|
FNC07872N
|
FNC07872C
|
UQCRFS1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
FXC07903
|
FHC07903
|
FNC07903N
|
FNC07903C
|
NDUFV2 |
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
FXC08018
|
FHC08018
|
FNC08018N
|
FNC08018C
|
CASP9 |
caspase 9, transcript variant alpha |
FXC08062
|
FHC08062
|
FNC08062N
|
FNC08062C
|
NDUFA10 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa |
FXC08150
|
FHC08150
|
FNC08150N
|
FNC08150C
|
SDHD |
succinate dehydrogenase complex, subunit D, integral membrane protein, transcript variant 1 |
FXC08233
|
FHC08233
|
FNC08233N
|
FNC08233C
|
AP2B1 |
adaptor-related protein complex 2, beta 1 subunit, transcript variant 1
|
FXC08267
|
FHC08267
|
|
|
PPARG |
peroxisome proliferator-activated receptor gamma, transcript variant 4 |
FXC08305
|
FHC08305
|
FNC08305N
|
FNC08305C
|
COX6A1 |
cytochrome c oxidase subunit VIa polypeptide 1 |
FXC08343
|
FHC08343
|
FNC08343N
|
FNC08343C
|
IFT57 |
intraflagellar transport 57 |
FXC08586
|
FHC08586
|
FNC08586N
|
FNC08586C
|
NDUFV1 |
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa, transcript variant 1 |
FXC08801
|
FHC08801
|
FNC08801N
|
FNC08801C
|
CASP3 |
caspase 3, apoptosis-related cysteine peptidase, transcript variant alpha |
FXC08865
|
FHC08865
|
FNC08865N
|
FNC08865C
|
NDUFB3 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa, transcript variant 1 |
FXC08953
|
FHC08953
|
FNC08953N
|
FNC08953C
|
COX7B |
cytochrome c oxidase subunit VIIb |
FXC08960
|
FHC08960
|
FNC08960N
|
FNC08960C
|
CYC1 |
cytochrome c-1 |
FXC09013
|
FHC09013
|
FNC09013N
|
FNC09013C
|
ATP5G2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) |
FXC09037
|
FHC09037
|
FNC09037N
|
FNC09037C
|
COX5A |
cytochrome c oxidase subunit Va |
FXC09137
|
FHC09137
|
FNC09137N
|
FNC09137C
|
DCTN4 |
dynactin 4 (p62), transcript variant 2 |
FXC09204
|
FHC09204
|
FNC09204N
|
FNC09204C
|
COX6A2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
FXC09312
|
FHC09312
|
FNC09312N
|
FNC09312C
|
DNAI1 |
dynein, axonemal, intermediate chain 1, transcript variant 1 |
FXC09331
|
FHC09331
|
FNC09331N
|
FNC09331C
|
NDUFA6 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa |
FXC09677
|
FHC09677
|
FNC09677N
|
FNC09677C
|
NDUFS2 |
NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC09693
|
FHC09693
|
FNC09693N
|
FNC09693C
|
NDUFS3 |
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) |
FXC09729
|
FHC09729
|
FNC09729N
|
FNC09729C
|
COX6B1 |
cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) |
FXC09747
|
FHC09747
|
FNC09747N
|
FNC09747C
|
COX7A2L |
cytochrome c oxidase subunit VIIa polypeptide 2 like |
FXC09862
|
FHC09862
|
FNC09862N
|
FNC09862C
|
VDAC1 |
voltage-dependent anion channel 1, transcript variant 1 |
FXC09931
|
FHC09931
|
FNC09931N
|
FNC09931C
|
POLR2J |
polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa |
FXC10177
|
FHC10177
|
FNC10177N
|
FNC10177C
|
PTGS1 |
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase), transcript variant 1 |
FXC10242
|
FHC10242
|
FNC10242N
|
FNC10242C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
NDUFA13 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 |
FXC10634
|
FHC10634
|
FNC10634N
|
FNC10634C
|
CLTB |
clathrin, light chain B, transcript variant 2 |
FXC10645
|
FHC10645
|
FNC10645N
|
FNC10645C
|
BAX |
BCL2-associated X protein, transcript variant beta |
FXC10662
|
FHC10662
|
FNC10662N
|
FNC10662C
|
NDUFC2 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa, transcript variant 1 |
FXC10813
|
FHC10813
|
FNC10813N
|
FNC10813C
|
SOD2 |
superoxide dismutase 2, mitochondrial, transcript variant 1 |
FXC10832
|
FHC10832
|
FNC10832N
|
FNC10832C
|
DCTN2 |
dynactin 2 (p50), transcript variant 3 |
FXC10987
|
FHC10987
|
FNC10987N
|
FNC10987C
|
TBP |
TATA box binding protein |
FXC11099
|
FHC11099
|
FNC11099N
|
FNC11099C
|
ATP5C1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1, transcript variant 1 |
FXC11490
|
FHC11490
|
FNC11490N
|
FNC11490C
|
PPIF |
peptidylprolyl isomerase F |
FXC11591
|
FHC11591
|
FNC11591N
|
FNC11591C
|
SDHA |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp), transcript variant 1 |
FXC11617
|
FHC11617
|
FNC11617N
|
FNC11617C
|
TGM2 |
transglutaminase 2, transcript variant 1 |
FXC11623
|
FHC11623
|
FNC11623N
|
FNC11623C
|
SIN3A |
SIN3 transcription regulator family member A, transcript variant 2 |
FXC11647
|
FHC11647
|
FNC11647N
|
FNC11647C
|
CREBBP |
CREB binding protein, transcript variant 1 |
FXC11778
|
FHC11778
|
FNC11778N
|
FNC11778C
|
COX7C |
cytochrome c oxidase subunit VIIc |
FXC11906
|
FHC11906
|
FNC11906N
|
FNC11906C
|
CASP8 |
caspase 8, apoptosis-related cysteine peptidase, transcript variant G |
FXC12541
|
FHC12541
|
FNC12541N
|
FNC12541C
|
TBPL2 |
TATA box binding protein like 2 |
FXC12596
|
FHC12596
|
FNC12596N
|
FNC12596C
|
COX4I1 |
cytochrome c oxidase subunit IV isoform 1 |
FXC13106
|
FHC13106
|
FNC13106N
|
FNC13106C
|
COX7A2 |
cytochrome c oxidase subunit VIIa polypeptide 2 (liver) |
FXC13423
|
FHC13423
|
FNC13423N
|
FNC13423C
|
NDUFV3 |
NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa, transcript variant 2 |
FXC14706
|
FHC14706
|
FNC14706N
|
FNC14706C
|
SLC25A6 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 |
FXC14765
|
FHC14765
|
FNC14765N
|
FNC14765C
|
VDAC2 |
voltage-dependent anion channel 2, transcript variant 2 |
FXC14809
|
FHC14809
|
FNC14809N
|
FNC14809C
|
HTT |
huntingtin |
FXC15881
|
FHC15881
|
FNC15881N
|
FNC15881C
|
ATP5E |
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
FXC16614
|
FHC16614
|
FNC16614N
|
FNC16614C
|
NDUFS5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC20237
|
FHC20237
|
FNC20237N
|
FNC20237C
|
ATP5F1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 |
FXC20471
|
FHC20471
|
FNC20471N
|
FNC20471C
|
SDHC |
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa, transcript variant 1 |
FXC20677
|
FHC20677
|
FNC20677N
|
FNC20677C
|
ATP5G3 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9), transcript variant 2 |
FXC21233
|
FHC21233
|
FNC21233N
|
FNC21233C
|
NDUFS1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC21290
|
FHC21290
|
FNC21290N
|
FNC21290C
|
UQCRC1 |
ubiquinol-cytochrome c reductase core protein I |
FXC21528
|
FHC21528
|
FNC21528N
|
FNC21528C
|
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
FXC21879
|
FHC21879
|
FNC21879N
|
FNC21879C
|
COX7B2 |
cytochrome c oxidase subunit VIIb2 |
FXC21906
|
FHC21906
|
FNC21906N
|
FNC21906C
|
UCP1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
FXC22063
|
FHC22063
|
FNC22063N
|
FNC22063C
|
NDUFS6 |
NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) |
FXC22122
|
FHC22122
|
FNC22122N
|
FNC22122C
|
NDUFS4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) |
FXC22169
|
FHC22169
|
FNC22169N
|
FNC22169C
|
VDAC3 |
voltage-dependent anion channel 3, transcript variant 1 |
FXC23255
|
FHC23255
|
FNC23255N
|
FNC23255C
|
UQCRB |
ubiquinol-cytochrome c reductase binding protein, transcript variant 1 |
FXC23350
|
FHC23350
|
FNC23350N
|
FNC23350C
|
NDUFB6 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa, transcript variant 1 |
FXC23492
|
FHC23492
|
FNC23492N
|
FNC23492C
|
COX8A |
cytochrome c oxidase subunit VIIIA (ubiquitous) |
FXC24280
|
FHC24280
|
FNC24280N
|
FNC24280C
|
GRM5 |
glutamate receptor, metabotropic 5, transcript variant b |
FXC24402
|
FHC24402
|
FNC24402N
|
FNC24402C
|
NDUFA12 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12, transcript variant 1 |
FXC24832
|
FHC24832
|
FNC24832N
|
FNC24832C
|
COX8C |
cytochrome c oxidase subunit VIIIC |
FXC25279
|
FHC25279
|
FNC25279N
|
FNC25279C
|
SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
FXC25949
|
FHC25949
|
|
|
ATP5H |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d, transcript variant 1 |
FXC26184
|
FHC26184
|
FNC26184N
|
FNC26184C
|
ATP5D |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit, transcript variant 1 |
FXC26369
|
FHC26369
|
FNC26369N
|
FNC26369C
|
CREB3L3 |
cAMP responsive element binding protein 3-like 3, transcript variant 1 |
FXC26402
|
FHC26402
|
FNC26402N
|
FNC26402C
|
BBC3 |
BCL2 binding component 3, transcript variant 2 |
FXC26711
|
FHC26711
|
FNC26711N
|
FNC26711C
|
ATP5J |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6, transcript variant 2 |
FXC27126
|
FHC27126
|
FNC27126N
|
FNC27126C
|
ATP5O |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit
|
FXC27161
|
FHC27161
|
|
|
SLC25A5 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
FXC27491
|
FHC27491
|
FNC27491N
|
FNC27491C
|
NDUFA1 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa |
FXC27495
|
FHC27495
|
FNC27495N
|
FNC27495C
|
UQCRH |
ubiquinol-cytochrome c reductase hinge protein, transcript variant 1 |
FXC27655
|
FHC27655
|
FNC27655N
|
FNC27655C
|
POLR2A |
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
FXC28428
|
FHC28428
|
FNC28428N
|
FNC28428C
|
UQCRQ |
ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa |
FXC29084
|
FHC29084
|
FNC29084N
|
FNC29084C
|
UQCR10 |
ubiquinol-cytochrome c reductase, complex III subunit X, transcript variant 1 |
FXC30961
|
FHC30961
|
FNC30961N
|
FNC30961C
|
HDAC2 |
histone deacetylase 2, transcript variant 1 |
|
FHC31712
|
FNC31712N
|
FNC31712C
|
CACNA2D2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2, transcript variant 1 |
FXC00563
|
FHC00563
|
FNC00563N
|
FNC00563C
|
ITGA7 |
inte |